Search
Latrepirdine H1-Antihistamine Action
smpdb.ca/view/SMP0062623Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaTemelastine H1-Antihistamine Action
smpdb.ca/view/SMP0062880Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Drugs: CalciumEnzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaBamipine H1-Antihistamine Action
smpdb.ca/view/SMP0062882Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Drugs: CalciumEnzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaPyrrobutamine H1-Antihistamine Action
smpdb.ca/view/SMP0062887Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Drugs: CalciumEnzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaTritoqualine H1-Antihistamine Action
smpdb.ca/view/SMP0062895Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaAzelastine H1-Antihistamine Action
smpdb.ca/view/SMP0060741Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaMizolastine H1-Antihistamine Action
smpdb.ca/view/SMP0060230Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaAlimemazine H1-Antihistamine Action
smpdb.ca/view/SMP0059689Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaFenethazine H1-Antihistamine Action
smpdb.ca/view/SMP0059707Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Drugs: CalciumEnzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaThenalidine H1-Antihistamine Action
smpdb.ca/view/SMP0062894Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alpha